EUVIMEDEUVIMED entdecken
Crossref

In Reply: The intersection of CHIP and HIV: Implications for cardiovascular risk stratification

Ohad Oren, Abhay Singh, Hetty E Carraway, Luke J Laffin, Steven E Nissen

Cleveland Clinic Journal of Medicine · 2026-08 · 93 (8) · 451.2-452

DOI: 10.3949/ccjm.93c.08002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cleveland Clinic Journal of Medicine, online erschienen am 03.08.2026. Verfasst von Ohad Oren und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Coordinating Center for Clinical Research, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reply: We thank Dr. Martinez and colleagues for their comment on the intersection between clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular risk in people with human immunodefi ciency virus (HIV) infection.We would like to shed light on recent data that may further inform this discussion.Since the REPRIEVE (Randomized Trial to Prevent Vascular Events in HIV) trial was completed, Xue et al 1 reported the results of a dedicated CHIP analysis in 4,490 REPRIEVE participants using high-depth targeted sequencing.While CHIP overall was not associated with major adverse cardiovascular events, larger CHIP clones (variant allele fraction ≥ 10%) were associated with substantially higher odds of major adverse cardiovascular events, myocardial infarction, and coronary revascularization. 1 Intriguingly, these associations persisted despite pitavastatin therapy, suggesting that a component of residual cardiovascular risk in people with HIV may be driven by mechanisms beyond reductions in low-density lipoprotein cholesterol, potentially involving NLRP3 inflammasome activation and downstream interleukin-1beta and interleukin-6 signaling.

Autor:innen und Institutionen

  • Cleveland Clinic Coordinating Center for Clinical Research, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.
  • Leukemia and Myeloid Disorders Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH.

Zitieren

APA

Oren, O., Singh, A., Carraway, H. E., Laffin, L. J., & Nissen, S. E. (2026). In Reply: The intersection of CHIP and HIV: Implications for cardiovascular risk stratification. Cleveland Clinic Journal of Medicine, 93(8), 451.2-452. https://doi.org/10.3949/ccjm.93c.08002

Vancouver

Oren O, Singh A, Carraway HE, Laffin LJ, Nissen SE. In Reply: The intersection of CHIP and HIV: Implications for cardiovascular risk stratification. Cleveland Clinic Journal of Medicine. 2026;93(8):451.2-452. doi:10.3949/ccjm.93c.08002

BibTeX
@article{Oren2026,
  author = {Oren, Ohad and Singh, Abhay and Carraway, Hetty E and Laffin, Luke J and Nissen, Steven E},
  title = {In Reply: The intersection of CHIP and HIV: Implications for cardiovascular risk stratification},
  journal = {Cleveland Clinic Journal of Medicine},
  year = {2026},
  volume = {93},
  number = {8},
  pages = {451.2--452},
  doi = {10.3949/ccjm.93c.08002}
}
Kostenlos starten →